Guangzhou NAGO Biotechnology Co., Ltd. was established in May 2014, located in the private science and technology park in Baiyun District, Guangzhou, with a total area of about 4,200 square meters, including a laboratory area of about 2,100 square meters.
In 2016, NAGO established the industry's highest purification level microbiology laboratory and irritation quantification research engineering center in China, allowing customers' products to have great improvement in anticorrosive safety and irritation, and is expected to expand to food and pharmaceuticals, providing the industry with safer anticorrosive solutions and more accurate and convenient irritation quantification methods. In 2018, we established a GMP standard fully automated antimicrobial agent production plant to ensure product supply in China region.
In 2020, we passed the ISO 9001:2015 quality management system certification to further strengthen our internal standardized management and improve the quality awareness of our products, and in 2021, our analytical center was accredited by the China National Accreditation Service for Conformity Assessment (CNAS) and granted CNAS accreditation.
In 2018, we established a GMP standard fully automated bacteriological inhibitor production plant in China.
NAGO’s laboratory has the ability of product research and development and can provide customers with high quality service, and has introduced more than 140 domestic and foreign instruments and equipment.
100,000-grade clean area with independent R&D application center, microbial testing center, efficacy testing center and physical and chemical testing center, which is a comprehensive biotechnology center integrating R&D - experiment - testing - production.
NAGO is dedicated to the development and application of new antimicrobial agents of natural origin to provide safer and less irritating antimicrobial solutions for the cosmetic industry, replacing the traditional formaldehyde retardant and isothiazolinone based traditional preservatives that are highly irritating, allergenic or carcinogenic to humans.
After two years of efforts, we have launched the A-series products which are in line with the market and have successfully applied for patents; the newly launched V-series products of plant-derived antimicrobial agents have been fully verified in the laboratory and market. Our products basically cover the diversified needs of cosmetics and reach the international top level in terms of cost, ease of use, safety and low irritation.
Close
QR code